Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection

ClinicalTrials.gov ID: NCT00371150

Public ClinicalTrials.gov record NCT00371150. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 2:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Describe the Antiviral Effect of Entecavir (ETV) in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection Who Are Nucleoside-Naive

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical research study is to develop observational clinical experience with the use of entecavir in participants who are either of Black/African-American race or of Hispanic ethnicity.

Study identification

NCT ID
NCT00371150
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
131 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2006
Primary completion
Feb 28, 2011
Completion
Feb 28, 2011
Last update posted
Apr 15, 2012

2006 – 2011

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Alabama Liver & Digestive Specialists (Alds) Montgomery Alabama 36116
University Of Arizona Tucson Arizona 85724
George Washington University Medical Center Washington D.C. District of Columbia 20037
University Of Miami Miami Florida 33136
Empire International Research Miami Florida 33144
University Of Chicago Chicago Illinois 60637
Banks Hepatology Institute, Pc College Park Maryland 20740
Brigham And Women'S Hospital Boston Massachusetts 02115
L L C Bda The Research Institute Springfield Massachusetts 01107
Va New York Harbor Healthcare System New York New York 10010
Westchester Digestive Disease Group, Llp Yonkers New York 10701
Albert Einstein Healthcare Network Philadelphia Pennsylvania 19141
Alamo Medical Research San Antonio Texas 78215
Hunter Holmes Mcguire D V A M C Richmond Virginia 23249

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00371150, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 15, 2012 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00371150 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →